Giorgio Perilongo
Overview
Explore the profile of Giorgio Perilongo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
2675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Benini F, Avagnina I, Giacomelli L, Papa S, Mercante A, Perilongo G
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454879
About 4 million children with an oncological disease worldwide require pediatric palliative care (PPC) due to the nature of their condition. PPC is not limited to end-of-life care; it is...
12.
Santini A, Avagnina I, Marinetto A, De Tommasi V, Lazzarin P, Perilongo G, et al.
Front Psychol
. 2022 Apr;
13:858812.
PMID: 35391957
Infants, children and adolescents with life-limiting and life-threatening disease need long-term care that may change according to disease's natural history. With the primary goal of quality of life, the psychologist...
13.
Bosa L, Di Chiara C, Gaio P, Cosma C, Padoan A, Cozzani S, et al.
Front Pediatr
. 2022 Feb;
10:815857.
PMID: 35223697
Background: To date, there's no evidence of an increased risk of SARS-CoV-2 infection or more severe COVID-19 in patients with inflammatory bowel disease (IBD). However, whether COVID-19 alters the clinical...
14.
Marzollo A, Bresolin S, Colavito D, Cani A, Gaio P, Bosa L, et al.
Front Pediatr
. 2021 Oct;
9:703056.
PMID: 34692603
Nodular lymphoid hyperplasia (NLH) is a lymphoproliferative disease caused by non-clonal expansion of lymphoid cells in the gut mucosa. Little is known about the pathogenesis of NLH, which is often...
15.
Cananzi M, Wohler E, Marzollo A, Colavito D, You J, Jing H, et al.
Hum Genet
. 2021 Jun;
140(9):1299-1312.
PMID: 34185153
Genetic defects of innate immunity impairing intestinal bacterial sensing are linked to the development of Inflammatory Bowel Disease (IBD). Although much evidence supports a role of the intestinal virome in...
16.
Adamson P, Perilongo G
Pediatr Blood Cancer
. 2021 Apr;
68 Suppl 2:e29009.
PMID: 33818889
No abstract available.
17.
Bosa L, Batura V, Colavito D, Fiedler K, Gaio P, Guo C, et al.
Sci Rep
. 2021 Mar;
11(1):5945.
PMID: 33723309
CARMIL2 is required for CD28-mediated co-stimulation of NF-κB signaling in T cells and its deficiency has been associated with primary immunodeficiency and, recently, very early onset inflammatory bowel disease (IBD)....
18.
Agosto C, Salamon E, Divisic A, Benedetti F, Giacomelli L, Shah A, et al.
Orphanet J Rare Dis
. 2021 Feb;
16(1):78.
PMID: 33573692
Background: We report the clinical outcomes observed in our patients with SMA type 1 or 2 receiving nusinersen, and we comment on the ethical implications of this treatment, in line...
19.
Porzionato A, Zaramella P, Dedja A, Guidolin D, Bonadies L, Macchi V, et al.
Am J Physiol Lung Cell Mol Physiol
. 2021 Jan;
320(5):L688-L704.
PMID: 33502939
Early therapeutic effect of intratracheally (IT)-administered extracellular vesicles secreted by mesenchymal stem cells (MSC-EVs) has been demonstrated in a rat model of bronchopulmonary dysplasia (BPD) involving hyperoxia exposure in the...
20.
Dona D, Masiero S, Costenaro P, Todeschini Premuda M, Rossin S, Perilongo G, et al.
Front Pediatr
. 2020 Dec;
8:594831.
PMID: 33330289
In the Veneto Region, an exponential spread of patients affected by 2019 novel Coronavirus disease (COVID-19) has been observed after February 21st. Since then, we have been evaluating children suspected...